2016 EU Drug Markets Report: In-depth Analysis


The EU Drug Markets Report 2016 is the second comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis provided in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade from production and trafficking to distribution. Taking an evidence-based approach, the report reviews the markets for cannabis, heroin, cocaine, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides concrete action points to inform policy development at EU and national level.

This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.

Read the 2016 EU Drug Markets Report: Strategic Overview for a summary of key findings.

An update of this publication is available in the EU Drug Markets Report 2019

Download as PDF

Download as ePub

Table of contents

  • Contents
  • Foreword
  • Introduction
  • Acknowledgements
  • Executive summary
  • Overview
  • PART I: Understanding the widespread ramifications of the drug market
  • Key issues
  • Chapter 1: The ramifications of the illicit drug market
  • Chapter 2: Drivers of drug market developments
  • PART II: Main drug markets in the EU
  • Chapter 3: Cannabis
  • Chapter 4: Heroin and other opioids
  • Chapter 5: Cocaine
  • Chapter 6: Amphetamine, methamphetamine and MDMA
  • Chapter 7: New psychoactive substances
  • PART III: Tackling the illicit drug market
  • Chapter 8: Drug supply reduction policies and responses
  • References
  • Abbreviations
  • Annex

Background papers